Multisystem inflammatory syndrome in adults after acute coronavirus disease 2019 in a Japanese woman: A case report.
COVID-19
Multisystem inflammatory syndrome
SARS-CoV-2
Journal
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
21
07
2021
revised:
22
09
2021
accepted:
26
09
2021
pubmed:
9
10
2021
medline:
20
11
2021
entrez:
8
10
2021
Statut:
ppublish
Résumé
Multisystem inflammatory syndrome in adults (MIS-A) is a rare and emerging syndrome after coronavirus disease 2019 (COVID-19). To the best of our knowledge, Japanese cases of MIS-A are rarely reported. Here, we describe a case of MIS-A in a 44-year-old Japanese woman presenting with multiorgan dysfunction (i.e., cardiovascular and mucocutaneous involvement) and markedly elevated inflammatory markers 2 weeks after recovery from COVID-19. Treatment with intravenous immunoglobulins and corticosteroids resolved her symptoms. On the 13th day, she was discharged from the hospital with no recurrences on follow-up. This study highlights the importance of recognizing this emerging syndrome when treating patients with multiorgan dysfunction after COVID-19.
Identifiants
pubmed: 34620535
pii: S1341-321X(21)00263-4
doi: 10.1016/j.jiac.2021.09.014
pmc: PMC8486615
pii:
doi:
Substances chimiques
Immunoglobulins, Intravenous
0
adult multisystem inflammatory disease, COVID-19 related
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
99-102Informations de copyright
Copyright © 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.